Volume 71, Issue 11 e31274
BRIEF REPORT

Supplemental Nutrition Assistance Program participation gaps within a pediatric leukemia clinical trial cohort

Rahela Aziz-Bose

Corresponding Author

Rahela Aziz-Bose

Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA

Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts, USA

Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA

Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts, USA

Correspondence

Rahela Aziz-Bose, Department of Pediatric Oncology, Dana-11, Dana-Farber Cancer Institute, Boston, MA 02215, USA.

Email: [email protected]

Search for more papers by this author
Colin Cernik

Colin Cernik

Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA

Search for more papers by this author
Puja J. Umaretiya

Puja J. Umaretiya

Division of Pediatric Hematology/Oncology, University of Texas Southwestern Medical Center, Dallas, Texas, USA

Search for more papers by this author
Lenka Ilcisin

Lenka Ilcisin

Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA

Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts, USA

Department of Pediatric Surgery, Boston Children's Hospital, Boston, Massachusetts, USA

Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA

Search for more papers by this author
Colleen A. Kelly

Colleen A. Kelly

Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA

Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts, USA

Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA

Search for more papers by this author
Ariana Valenzuela

Ariana Valenzuela

Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA

Search for more papers by this author
Charlotte Bruce

Charlotte Bruce

Department of Pediatrics, Boston Medical Center, Boston, Massachusetts, USA

Search for more papers by this author
Stephanie Ettinger de Cuba

Stephanie Ettinger de Cuba

Department of Health Law, Policy & Management, Boston University School of Public Health, Boston, Massachusetts, USA

Search for more papers by this author
Peter D. Cole

Peter D. Cole

Rutgers Cancer Institute, New Brunswick, New Jersey, USA

Search for more papers by this author
Lisa M. Gennarini

Lisa M. Gennarini

Montefiore Medical Center, Bronx, New York, USA

Search for more papers by this author
Justine M. Kahn

Justine M. Kahn

Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, Columbia University Irving Medical Center, New York, New York, USA

Search for more papers by this author
Kara M. Kelly

Kara M. Kelly

Department of Pediatrics, Roswell Park Comprehensive Cancer Center, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, New York, USA

Search for more papers by this author
Bruno Michon

Bruno Michon

Centre Hospitalier Universitaire de Quebec, Saint-Foy, Quebec, Canada

Search for more papers by this author
Thai-Hoa Tran

Thai-Hoa Tran

Division of Pediatric Hematology/Oncology, Charles-Bruneau Cancer Center, CHU Ste-Justine, University of Montreal, Montreal, Quebec, Canada

Search for more papers by this author
Jennifer J. G. Welch

Jennifer J. G. Welch

Division of Pediatric Hematology/Oncology, Hasbro Children's Hospital/Brown University, Providence, Rhode Island, USA

Search for more papers by this author
Lewis B. Silverman

Lewis B. Silverman

Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, Columbia University Irving Medical Center, New York, New York, USA

Search for more papers by this author
Kira Bona

Kira Bona

Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA

Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts, USA

Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA

Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts, USA

Search for more papers by this author
First published: 11 August 2024
Citations: 1

Previously presented as an abstract at the AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorites and the Medically Underserved, Philadelphia, PA, USA; 2022.

Abstract

Poverty-exposed children with cancer are more likely to experience adverse outcomes. Supplemental Nutrition Assistance Program (SNAP) benefits improve food insecurity and child health outcomes, and could be used to mitigate disparities. We conducted a secondary analysis of parent-reported data collected in a frontline pediatric leukemia trial (NCT03020030) to assess SNAP eligibility (proxied by other means-tested program participation) and participation. At diagnosis, 105/287 families (37%) were SNAP-eligible, of whom 53 (50%) were SNAP participants. At 6 months, 104/257 families (41%) were SNAP-eligible, and 59 (57%) were SNAP participants. Interventions to increase benefits participation during childhood cancer treatment represent an immediate opportunity to reduce disparities.

CONFLICT OF INTEREST STATEMENT

The authors declare no conflicts of interest.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.